After inking a related patent settlement last year, Viatris has cleared another obstacle in its quest to launch generic ...

A federal court ruled in Mylan's favor, finding no infringement of Novo's patent tied to Wegovy, rejecting direct, ...

Mylan said its generic version would be 30 per cent cheaper, resulting in a saving to the HSE of €42 million a year were it to use the drug. Savings ...

Pfizer is spinning off its off-patent and generics business UpJohn, and combining it with generic drugmaker Mylan to create a giant off-patent group with global annual revenues worth about $20 ...

Mylan raised EpiPen prices "to get filthy rich at the expense of our constituents," Rep. Elijah Cummings, D-Md., said at the House Oversight Committee hearing. Bresch, however, stood her ground ...

Mylan has said insurance generally covers the cost of the EpiPen. But that doesn’t shield patients from high co-payments, deductibles or other cost sharing.

Australians are reassured they are unlikely to face big price hikes for the EpiPen, a life-saving anti-allergy device, despite a controversial 400-per-cent-cost increase in the United States.